Black FridayUp to 80% OFF
Humacyte, Inc.Humacyte, Inc.Humacyte, Inc.

Humacyte, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsForecastsSeasonalsOptionsETFs

Community discussions


Not many stocks are in as precarious a position as HUMA is right now. Battling for its life not to fall down into the sub-dollar pit at the same time the entire stock market is in the grips of a snarling bear. Do you dare go where it is darkest to fight the good fight risking injury and pain for a chance at ultimate glory? Or do you curl up safely under a blanky and wait out the cold until it is a bright spring outside and flowers blooming?
ayip12
HUMA even good news can’t help this stock
HUMA this looks interesting....starting my DD on this company today. Any insight would be appreciated:)
HUMA Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
ayip12
HUMA is it true this is the only company that is contracted by dept of defense?
HUMA Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3, today. Price target 18$. Load up, boys and girls.
Canarytraderjoe
HUMA

candle trading: we in a inverted hammer after major rejection (delay) of resistance

wyckoff trading: currently at LPS fase (last point of support) after a test/spring fase. all the way down to 3,40 (i did buy more even with all the negative sentiment, and it played off) if it breaks to the upside(what it will in my opinion) it will break the 7,50 resistance (the sell off after approval) and will flirt with the SPAC price around 10-12$.. i will sell partially (30% of total shares) and hope it will drop so i can accumulate more.. because i still think this revolutionary graft will be adopted sooner then later.. they have so many partnerships and those partners have alot of patients. (dod/Fresenius) Q1 earnings. if we hit above 250k like estimate then we could be in a suprise to 25$ because the cagr in % will be higher and people will buy it like a growth company. if this really is alot higher then expected.. then i think this company could go 30-55$ end of 2025.

alot of negativity about healthcare sector at moment.. if that turns around and we are already pumping.. i believe it can go even higher then 55$

but my base case:
short term (60days); 8-12ish
medium term (60 days to a year): 12-25 if Q1 positive at the high end. if whole healthcare space flips around it could go 25-50ish.. and could be an specular asset. then 3digit stock

long:
bear; no earnings 6-12
neutral; with estimated earnings 12-25
bullish; earnings suprise 25-50
fomo; earnings suprise and good news other applications

and i do think it will be 3/4 .
im bias because 30% of portfolio in this stock.

my targetprices:
$12 (-30% shares)
$25 (-30% of shares left)(so have 50% left)
$50 (-30% of shares left)(so have 35% left)
$100(-30% of shares left)(so have 20% left)
$150(-30% of shares left)(so have 14% left)

this i hold for dear life and hope dividends are coming in the future.

i also hold Fresenius medical. and will buy if humacyte rises.

if they are planning to sell it all to a big company.. an acquisition.. then i will be happy already because that will be at least 12-25$ range. and then i will put those profits mostly in other chances
getdabuzz
HUMA I smell something iffy. They claim on their website that that their products have been used on solders in Ukraine, I believe last year. How come they are not releasing the results? You get my point.